Peroxisome proliferator-activated receptors ligands, oxidative stress, and cardiac fibroblast extracellular matrix turnover.
Villarreal
Francisco J
FJ
Asbun
Juan
J
D000804:Angiotensin II / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D005109:Extracellular Matrix / Q000502:physiology*; D005347:Fibroblasts / Q000502:physiology*; D006801:Humans; D008024:Ligands; D009206:Myocardium / Q000166:cytology*; D018384:Oxidative Stress / Q000502:physiology*; D047492:Peroxisome Proliferator-Activated Receptors / Q000502:physiology*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000494:pharmacology
D047228:Angiotensin II Type 1 Receptor Blockers; D000975:Antioxidants; D008024:Ligands; D047492:Peroxisome Proliferator-Activated Receptors; D045162:Thiazolidinediones; D000804:Angiotensin II; D000077205:Pioglitazone